JP2001512449A - 細胞増殖を阻害するペプチド及びその使用 - Google Patents

細胞増殖を阻害するペプチド及びその使用

Info

Publication number
JP2001512449A
JP2001512449A JP53522498A JP53522498A JP2001512449A JP 2001512449 A JP2001512449 A JP 2001512449A JP 53522498 A JP53522498 A JP 53522498A JP 53522498 A JP53522498 A JP 53522498A JP 2001512449 A JP2001512449 A JP 2001512449A
Authority
JP
Japan
Prior art keywords
phe
cells
gly
terminal
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP53522498A
Other languages
English (en)
Japanese (ja)
Inventor
ミューレン，フォルカー ター
シュナイダー−シャウリーズ，ジビレ
Original Assignee
シェリング アクチェンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シェリング アクチェンゲゼルシャフト filed Critical シェリング アクチェンゲゼルシャフト
Publication of JP2001512449A publication Critical patent/JP2001512449A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP53522498A 1997-02-17 1998-01-30 細胞増殖を阻害するペプチド及びその使用 Pending JP2001512449A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19708454A DE19708454A1 (de) 1997-02-17 1997-02-17 Die Proliferation von Zellen inhibierendes Peptid und dessen Verwendung
DE19708454.0 1997-02-17
PCT/DE1998/000326 WO1998035983A1 (de) 1997-02-17 1998-01-30 Die proliferation von zellen inhibierendes peptid und dessen verwendung

Publications (1)

Publication Number Publication Date
JP2001512449A true JP2001512449A (ja) 2001-08-21

Family

ID=7822000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53522498A Pending JP2001512449A (ja) 1997-02-17 1998-01-30 細胞増殖を阻害するペプチド及びその使用

Country Status (7)

Country Link
EP (1) EP0975661A1 (de)
JP (1) JP2001512449A (de)
AU (1) AU6391598A (de)
CA (1) CA2281033A1 (de)
DE (1) DE19708454A1 (de)
IL (1) IL131409A0 (de)
WO (1) WO1998035983A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof

Also Published As

Publication number Publication date
EP0975661A1 (de) 2000-02-02
DE19708454A1 (de) 1998-08-27
WO1998035983A1 (de) 1998-08-20
AU6391598A (en) 1998-09-08
CA2281033A1 (en) 1998-08-20
IL131409A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
KR100767554B1 (ko) 암 억제 유전자 더블유티1의 생산물에 기초한 암항원
RU2435782C2 (ru) Hla-a*3303-рестриктированный пептид wt1 и содержащая его фармацевтическая композиция
EP1105419B1 (de) Verfahren für die behandlung der multiplen sklerose mittels peptidanalogen des menschlichen basischen myelinproteins
AU2012257774C1 (en) High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain
US8071716B2 (en) Thymus-specific protein
JP2002502594A (ja) 神経保護ペプチドおよびその使用
US8663647B2 (en) Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
TW200906850A (en) TEM8 peptides and vaccines comprising the same
JP2000512277A (ja) ペプチド誘導体
CN110248953A (zh) 新型订书肽及其用途
JP2001512449A (ja) 細胞増殖を阻害するペプチド及びその使用
CN113336829A (zh) 靶向anp32a抗白血病的小分子肽及其制备方法和应用
KR101109163B1 (ko) 타이로신-세린-발린(ｙｓｖ)을 포함하는 생물학적 활성펩티드
JPS62501502A (ja) 免疫調節性ペプチド
JP5924593B2 (ja) 抗癌剤の活性増強剤
US20230414732A1 (en) Compositions of embedded epitope random peptides (eerp) for treatment of immune-mediated conditions, and methods of use
WO2023163094A1 (ja) 成人ｔ細胞白血病の治療又は予防のための医薬組成物
TWI658832B (zh) 用於抑制骨髓衍生抑制細胞之組成物
KR20230120543A (ko) c-Met의 에피토프를 포함하는 암 백신 및 이의 용도
JPH03170498A (ja) ペプチドおよびこのペプチドを含有する薬剤
AU2017214321A1 (en) Methods of generating populations of tumour-infiltrating T cells